| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| HAMILTON THORNE Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 284,40 | 0,00 % | Nike & Lululemon drehen auf! Broadcom | Oracle | United Health | D-Wave Quantum | Tag 2 nach der Zinssenkung: Die Märkte wirken stabil, gleichzeitig setzt sich eine leichte Rotation fort - Tech kühlt ab, während der Dow Jones in Richtung Rekordzone marschiert. Für den S&P 500 bleibt... ► Artikel lesen | |
| MEDTRONIC | 83,20 | +0,05 % | Medtronic: Will a Robot Help Perform Your Next Surgery? | FDA clears the Medtronic Hugo robotic-assisted surgery system for urologic procedures. NORTHAMPTON, MA / ACCESS Newswire / December 15, 2025 / James Choate-Deeds and his wife Caryn held hands and braced... ► Artikel lesen | |
| INTUITIVE SURGICAL | 468,60 | -0,73 % | Intuitive Surgical, Inc.: Intuitive Announces Expanded Indications for da Vinci SP | SUNNYVALE, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that... ► Artikel lesen | |
| TELADOC HEALTH | 6,295 | -0,25 % | Forget Teladoc and Buy This Healthcare Stock Instead | ||
| SERNOVA BIOTHERAPEUTICS | 0,077 | -3,77 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort | EQS-News: SYNLAB
/ Schlagwort(e): Strategische Unternehmensentscheidung
Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort
23.10.2025... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update | -- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --
-- Delivered $1.0 Million of Operating Income in Q3 2025 --
SAN DIEGO... ► Artikel lesen | |
| HCA HEALTHCARE | 394,50 | -1,33 % | Dividendenbekanntmachungen (15.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A&W FOOD SERVICES OF CANADA INC CA0002251027 0,48 CAD 0,2969 EUR AMERICAN HOMES 4 RENT US02665T3068 0,3 USD 0,2555 EUR ARES CAPITAL... ► Artikel lesen | |
| LANTHEUS | 56,04 | +1,01 % | Truist Securities upgrades Lantheus stock to Buy on growth prospects | ||
| ENVISTA | 18,900 | +1,07 % | Envista Holdings Corporation: Envista Reports Third Quarter 2025 Results | BREA, Calif., Oct. 29, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended September 26, 2025."This was another strong quarter... ► Artikel lesen | |
| CAREDX | 16,380 | -0,70 % | CareDx, Inc. - 8-K, Current Report | ||
| GT BIOPHARMA | 0,711 | 0,00 % | GT Biopharma, Inc. Offers Near-Term Catalyst Opportunity with Advancing Phase 1 Trials | NAPLES, FL / ACCESS Newswire / November 19, 2025 / Patients battling aggressive blood cancers face limited treatment options and uncertain outcomes. Scientists have increasingly turned to the body's... ► Artikel lesen | |
| SYNEOS HEALTH | - | - | Research Solutions, Inc.: Research Solutions Reports First Quarter Fiscal Year 2026 Results | Reports 21% Increase in ARR to $21.3 Million, Strong Growth in Net Income, Adjusted EBITDA and Operating Cash Flow
HENDERSON, Nev., Nov. 13, 2025 /PRNewswire/... ► Artikel lesen | |
| CARMAT | 0,099 | -100,00 % | CARMAT Provides an Update on the Ongoing Receivership Procedure | The Versailles Economic Court has opted for the takeover bid within the context of a sales plan submitted by CARMAT SAS and approved the sale plan1 of CARMAT SA to CARMAT SAS
Regulatory News:
CARMAT... ► Artikel lesen | |
| CHEMOMETEC | 90,15 | +0,28 % | Chemometec A/S: Growth in revenue and operating profit | Trading statement for Q1 2025/26 (1 July - 30 September 2025) Growth in revenue and operating profit Revenue was up by 8% in Q1 2025/26 (11% at constant exchange rates) to DKK 124.6 million from DKK... ► Artikel lesen |